Published in Exp Eye Res on March 01, 2004
Structure, evolution, and biology of the MUC4 mucin. FASEB J (2007) 1.75
Functions of ocular surface mucins in health and disease. Curr Opin Allergy Clin Immunol (2008) 1.67
The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture. Invest Ophthalmol Vis Sci (2007) 1.65
Mucin characteristics of human corneal-limbal epithelial cells that exclude the rose bengal anionic dye. Invest Ophthalmol Vis Sci (2006) 1.62
Membrane-tethered mucins have multiple functions on the ocular surface. Exp Eye Res (2010) 1.54
Assay of mucins in human tear fluid. Exp Eye Res (2007) 1.44
Tear lipocalin captures exogenous lipid from abnormal corneal surfaces. Invest Ophthalmol Vis Sci (2009) 1.19
Release of membrane-associated mucins from ocular surface epithelia. Invest Ophthalmol Vis Sci (2008) 1.18
Tear lipocalin: evidence for a scavenging function to remove lipids from the human corneal surface. Invest Ophthalmol Vis Sci (2005) 1.11
Examination of the restoration of epithelial barrier function following superficial keratectomy. Exp Eye Res (2006) 1.05
Glycan structures of ocular surface mucins in man, rabbit and dog display species differences. Glycoconj J (2008) 0.99
Resolution of persistent corneal erosion after administration of topical rebamipide. Clin Ophthalmol (2012) 0.96
A metalloproteinase secreted by Streptococcus pneumoniae removes membrane mucin MUC16 from the epithelial glycocalyx barrier. PLoS One (2012) 0.95
Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patients. Clin Ophthalmol (2010) 0.92
Dry eye disease and microbial keratitis: is there a connection? Ocul Surf (2013) 0.92
Mass spectrometric identification of phospholipids in human tears and tear lipocalin. Invest Ophthalmol Vis Sci (2012) 0.90
The suprabasal layer of corneal epithelial cells represents the major barrier site to the passive movement of small molecules and trafficking leukocytes. Br J Ophthalmol (2006) 0.89
Exfoliative epitheliopathy of bullous keratopathy with breaches in the MUC16 Glycocalyx. Invest Ophthalmol Vis Sci (2009) 0.89
IL-13 Stimulates Proliferation and Expression of Mucin and Immunomodulatory Genes in Cultured Conjunctival Goblet Cells. Invest Ophthalmol Vis Sci (2015) 0.89
The spectrophotometric sulfo-phospho-vanillin assessment of total lipids in human meibomian gland secretions. Lipids (2013) 0.88
Topical rebamipide improves lid wiper epitheliopathy. Clin Ophthalmol (2013) 0.88
In vitro activity of human beta-defensin 2 against Pseudomonas aeruginosa in the presence of tear fluid. Antimicrob Agents Chemother (2007) 0.88
Establishing the tolerability and performance of tamarind seed polysaccharide (TSP) in treating dry eye syndrome: results of a clinical study. BMC Ophthalmol (2007) 0.87
Topical rebamipide improves the ocular surface in mild lagophthalmos. Clin Ophthalmol (2013) 0.87
Quantitative analysis of tear film fluorescence and discomfort during tear film instability and thinning. Invest Ophthalmol Vis Sci (2013) 0.87
Scale and spatial distribution of aberrations associated with tear breakup. Optom Vis Sci (2012) 0.87
MUC16 expression in Sjogren's syndrome, KCS, and control subjects. Mol Vis (2008) 0.87
Immunohistochemical analysis of secretoglobin SCGB 2A1 expression in human ocular glands and tissues. Histochem Cell Biol (2006) 0.86
HN125: A Novel Immunoadhesin Targeting MUC16 with Potential for Cancer Therapy. J Cancer (2011) 0.86
A model for tear film thinning with osmolarity and fluorescein. Invest Ophthalmol Vis Sci (2014) 0.85
MUC5AC overexpression in tear film of neonates. Graefes Arch Clin Exp Ophthalmol (2007) 0.85
MUC1 expression in Sjogren's syndrome, KCS, and control subjects. Mol Vis (2010) 0.85
Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal. Clin Ophthalmol (2014) 0.85
Mucin deficiency causes functional and structural changes of the ocular surface. PLoS One (2012) 0.84
Coarse-grained modeling of mucus barrier properties. Biophys J (2012) 0.84
A novel antimicrobial peptidoglycan recognition protein in the cornea. Invest Ophthalmol Vis Sci (2009) 0.83
Computed tear film and osmolarity dynamics on an eye-shaped domain. Math Med Biol (2015) 0.83
Safety and efficacy of MIM-D3 ophthalmic solutions in a randomized, placebo-controlled Phase 2 clinical trial in patients with dry eye. Clin Ophthalmol (2013) 0.83
Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins. Exp Eye Res (2013) 0.82
Conservative treatment for late-onset bleb leaks after trabeculectomy with mitomycin C in patients with ocular surface disease. Clin Ophthalmol (2012) 0.81
Suppression of Toll-like receptor-mediated innate immune responses at the ocular surface by the membrane-associated mucins MUC1 and MUC16. Mucosal Immunol (2015) 0.81
Calcium regulation by thermo- and osmosensing transient receptor potential vanilloid channels (TRPVs) in human conjunctival epithelial cells. Histochem Cell Biol (2012) 0.81
Image-guided evaluation and monitoring of treatment response in patients with dry eye disease. Graefes Arch Clin Exp Ophthalmol (2014) 0.80
Tissue distribution of the secretory protein, SPLUNC1, in the human fetus. Histochem Cell Biol (2005) 0.80
Not all lacrimal epithelial cells are created equal-heterogeneity of the rabbit lacrimal gland and differential secretion. Curr Eye Res (2011) 0.80
Review: The Lacrimal Gland and Its Role in Dry Eye. J Ophthalmol (2016) 0.80
Nanotechnology in corneal neovascularization therapy--a review. J Ocul Pharmacol Ther (2013) 0.79
The ocular surface phenotype of Muc5ac and Muc5b null mice. Invest Ophthalmol Vis Sci (2014) 0.79
α-Melanocyte-stimulating hormone ameliorates ocular surface dysfunctions and lesions in a scopolamine-induced dry eye model via PKA-CREB and MEK-Erk pathways. Sci Rep (2015) 0.79
Effects of the loss of conjunctival Muc16 on corneal epithelium and stroma in mice. Invest Ophthalmol Vis Sci (2014) 0.79
Corneal epithelial cells function as surrogate schwann cells for their sensory nerves. Glia (2016) 0.79
Effect of proinflammatory cytokines on the human MUC5AC promoter activity in vitro and in vivo. Clin Ophthalmol (2007) 0.78
A novel mechanism of increased infections in contact lens wearers. Invest Ophthalmol Vis Sci (2011) 0.78
A novel fluorescent lipid probe for dry eye: retrieval by tear lipocalin in humans. Invest Ophthalmol Vis Sci (2013) 0.78
Regulation of the membrane mucin Muc4 in corneal epithelial cells by proteosomal degradation and TGF-beta. J Cell Physiol (2010) 0.78
Tear film dynamics with evaporation, wetting, and time-dependent flux boundary condition on an eye-shaped domain. Phys Fluids (1994) (2014) 0.77
Image processing techniques to quantify microprojections on outer corneal epithelial cells. J Anat (2008) 0.77
Expression analysis of the transmembrane mucin MUC20 in human corneal and conjunctival epithelia. Invest Ophthalmol Vis Sci (2014) 0.77
Molecular mechanism of ocular surface damage: application to an in vitro dry eye model on human corneal epithelium. Mol Vis (2011) 0.77
Epidemic Keratoconjunctivitis-Causing Adenoviruses Induce MUC16 Ectodomain Release To Infect Ocular Surface Epithelial Cells. mSphere (2016) 0.76
A MODEL FOR THE TEAR FILM AND OCULAR SURFACE TEMPERATURE FOR PARTIAL BLINKS. Interfacial Phenom Heat Transf (2015) 0.76
The tear fluid mucin 5AC change of primary angle-closure glaucoma patients after short-term medications and phacotrabeculectomy. Mol Vis (2010) 0.76
Potential candidate cells for constructing tissue-engineered lacrimal duct epithelium: a histological and cytological study in rabbits. J Zhejiang Univ Sci B (2015) 0.75
Eukaryotic protein glycosylation: a primer for histochemists and cell biologists. Histochem Cell Biol (2016) 0.75
Novel Technique of Transepithelial Corneal Cross-Linking Using Iontophoresis in Progressive Keratoconus. J Ophthalmol (2016) 0.75
Role of TGFBIp in Wound Healing and Mucin Expression in Corneal Epithelial Cells. Yonsei Med J (2017) 0.75
Effect of dihydrotestosterone on the expression of mucin 1 and the activity of Wnt signaling in mouse corneal epithelial cells. Int J Ophthalmol (2016) 0.75
Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye. Optom Vis Sci (2015) 0.75
Ocular surface mucins and local inflammation-studies in genetically modified mouse lines. BMC Ophthalmol (2015) 0.75
Dry Eye Disease in Patients with Functioning Filtering Blebs after Trabeculectomy. PLoS One (2016) 0.75
Nanomedicine approaches for corneal diseases. J Funct Biomater (2015) 0.75
Characterization of ocular gland morphology and tear composition of pinnipeds. Vet Ophthalmol (2012) 0.75
Quantification of MUCIN 1, cell surface associated and MUCIN16, cell surface associated proteins in tears and conjunctival epithelial cells collected from postmenopausal women. Mol Vis (2013) 0.75
Concentrations of MUC16 and MUC5AC using three tear collection methods. Mol Vis (2017) 0.75
Effect of rebamipide ophthalmic suspension on the success of lacrimal stent intubation. Graefes Arch Clin Exp Ophthalmol (2015) 0.75
Comparison of the effects of different lens-cleaning solutions on the protein profiles of human conjunctival cells. Graefes Arch Clin Exp Ophthalmol (2012) 0.75
MUC5AC in juvenile conjunctival nevus. Jpn J Ophthalmol (2011) 0.75
Invisible Shield: Review of the Corneal Epithelium as a Barrier to UV Radiation, Pathogens, and Other Environmental Stimuli. J Ophthalmic Vis Res (2017) 0.75
Meibomian gland loss due to trabeculectomy. Jpn J Ophthalmol (2014) 0.75